Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
P
Pérez-Muñoz, Israel
Department of Orthopaedic Surgery, Ramón y Cajal University Hospital
(
P 157
)
MOLECULAR SCREENING OF ADVANCED SARCOMAS THROUGH NEXT-GENERATION SEQUENCING IN A TERTIARY UNIVERSITY HOSPITAL
Israel Pérez-Muñoz
Favorite
Pabst, Kim
Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen
(
P 176
)
FIBROBLAST ACTIVATION PROTEIN ALPHA AS THERANOSTIC TARGET IN SARCOMA
Kim Pabst
Favorite
Padmore, Greg
University of Calgary
(
P 205
)
PREOPERATIVE CHEMORADIATION (MODIFIED EILBER PROTOCOL) VERSUS NEOADJUVANT/ ADJUVANT RADIOTHERAPY FOR SOFT TISSUE EXTREMITY SARCOMAS: A POPULATION BASED ANALYSIS IN ALBERTA
Greg Padmore
Favorite
Paioli, Anna
Rizzoli orthopedic Institute IRCCS
(
P 031
)
PAZOPANIB IN ADVANCED BONE SARCOMA: A RETROSPECTIVE ANALYSIS OF RIZZOLI ORTHOPEDIC INSTITUTE
Anna Paioli
Favorite
Palassini, Elena
Fondazione IRCCS Istituto Nazionale dei Tumori
(
P 052
)
PATHOLOGICAL AND RADIOLOGICAL RESPONSE AFTER NEOADJUVANT TREATMENTS IN PRIMARY RESECTABLE MYXOFIBROSARCOMA AND UNDIFFERENTIATED PLEOMORPHIC SARCOMA OF THE EXTREMITIES AND TRUNK WALL
Elena Palassini
Favorite
Palma, Norma Alonzo
Aadi Bioscience
(
P 156
)
MANAGEMENT OF ADVERSE EVENTS IN THE AMPECT TRIAL OF NAB-SIROLIMUS FOR THE TREATMENT OF ADVANCED MALIGNANT PECOMA
Norma Alonzo Palma
Favorite
Palmerini, Emanuela
IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
(
P 031
)
PAZOPANIB IN ADVANCED BONE SARCOMA: A RETROSPECTIVE ANALYSIS OF RIZZOLI ORTHOPEDIC INSTITUTE
Emanuela Palmerini
Favorite
(
P 038
)
TENOSYNOVIAL GIANT CELL TUMOR OBSERVATIONAL PLATFORM PROJECT (TOPP): 2-YEAR OBSERVATIONAL SUB-ANALYSIS OF AGE AND PATIENT-REPORTED OUTCOMES FROM AN EU/US PROSPECTIVE REGISTRY
Emanuela Palmerini
Favorite
(
P 102
)
EFFICACY AND SAFETY OF VIMSELTINIB IN TENOSYNOVIAL GIANT CELL TUMOUR: PHASE 2 EXPANSION
Emanuela Palmerini
Favorite
(
P 245
)
MUTATIONAL STATUS OF CHONDROSARCOMA BASED ON TARGETED NEXT-GENERATION SEQUENCING ANALYSIS
Emanuela Palmerini
Favorite
Palmu, Sauli
Tampere University and Tampere University Hospital
(
P 043
)
A MULTICENTER, OPEN-LABEL, RANDOMIZED, PHASE 2 STUDY OF LENVATINIB IN COMBINATION WITH IFOSFAMIDE AND ETOPOSIDE VERSUS IFOSFAMIDE AND ETOPOSIDE IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY OSTEOSARCOMA
Sauli Palmu
Favorite
Pal, Rajesh
Precision Sarcoma Research Group
(
P 231
)
COMPREHENSIVE MOLECULAR PROFILING OF FOLLICULAR DENDRITIC CELL SARCOMA
Rajesh Pal
Favorite
Pandya, Pankita
Indiana University
(
P 192
)
TARGETING PI3K/MTOR MITIGATES RESISTANCE TO CDK4/6 INHIBITION IN RB-PROFICIENT PEDIATRIC AND AYA OSTEOSARCOMAS
Pankita Pandya
Favorite
Pan, Haitao
St. Jude Children's Research Hospital
(
P 012
)
ACUTE CARDIAC CHANGES IN PEDIATRIC AND YOUNG ADULT SOLID TUMOR PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS
Haitao Pan
Favorite
Pan, Irene
United BioSource LLC
(
P 066
)
CHARACTERISTICS OF PATIENTS RECEIVING PEXIDARTINIB IN THE REAL-WORLD SETTING: A CROSS-SECTIONAL SURVEY
Irene Pan
Favorite
Pantano, Francesco
Campus Bio-Medico University of Rome
(
P 185
)
PHARMACOLOGICAL INHIBITION OF GLYOXALASE-1 AS NOVEL THERAPEUTIC STRATEGY TO POTENTIATE TRABECTEDIN ANTI-TUMOR EFFECT IN SOFT TISSUE SARCOMA PRECLINICAL MODELS
Francesco Pantano
Favorite
Papakonstantinou, Andri
Karolinska University Hospital
(
P 204
)
PERCEPTIONS AND MANAGEMENT PRACTICES OF SARCOMA EXPERTS ABOUT SOFT TISSUE SARCOMA PATIENTS WITH ISOLATED LUNG METASTASES ACROSS EUROPE
Andri Papakonstantinou
Favorite
Park, Changhee
Seoul National University Hospital
(
P 265
)
DEVELOPMENT OF THERAPEUTIC STRATEGY FOR DESMOID TUMOR WITH NOVEL PATIENT-DERIVED PRECLINICAL MODEL
Changhee Park
Favorite
Park, Jae Berm
Samsung Medical Center
(
P 212
)
COMPARISON OF SURGICAL OUTCOMES BETWEEN LEIOMYOSARCOMA OF INFERIOR VENA CAVA AND OTHER LOCATIONS
Jae Berm Park
Favorite
(
P 215
)
FEASIBILITY AND ADVANTAGE OF PRE-OPERATIVE RADIOTHERAPY IN RETROPERITONEAL SARCOMA
Jae Berm Park
Favorite
Park, Jason
University of Texas Southwestern Medical Center
(
P 104
)
INFANTILE EXTRARENAL SPINDLE CELL MESENCHYMAL NEOPLASMS WITH TARGETABLE EGFR KINASE DOMAIN DUPLICATIONS
Jason Park
Favorite
Park, Sang Woo (Sean)
Samsung Medical Center
(
P 215
)
FEASIBILITY AND ADVANTAGE OF PRE-OPERATIVE RADIOTHERAPY IN RETROPERITONEAL SARCOMA
Sang Woo (Sean) Park
Favorite
Park, Se Jun
Seoul St. Mary’s Hospital, The Catholic University of Korea
(
P 153
)
IFOSFAMIDE/ETOPOSIDE/CARBOPLATIN REGIMEN AS A POST DOXORUBICIN TREATMENT IN METASTATIC OR RECURRENT SOFT TISSUE SARCOMA
Se Jun Park
Favorite
Park, Ye-Jean
University of Calgary McCaig Bone and Joint Institute
(
P 142
)
USE OF SMALL MOLECULE STIMULATE OF TYPE-1 INTERFERON GENES (STING) AGONIST IMMUNOTHERAPY FOR CANINE SARCOMA: A CROSS-SPECIES ANALYSIS
Ye-Jean Park
Favorite
Pasquali, Sandro
Molecular Pharmacology Unit, Department of Research and Sarcoma Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori
(
P 01
)
ANTITUMOR ACTIVITY OF CYTOTOXIC AND TARGETED AGENTS IN A PATIENT-DERIVED XENOGRAFT (PDX) OF DESMOPLASTIC SMALL ROUND CELL TUMOR (DSRCT) HIGHLIGHTS THE IRINOTECAN-TRABECTEDIN COMBINATION
Sandro Pasquali
Favorite
(
P 170
)
ANTITUMOR ACTIVITY OF TAZEMETOSTAT AND DOXORUBICIN COMBINATION ON PATIENT-DERIVED PRECLINICAL MODELS OF EPITHELIOID SARCOMA
Sandro Pasquali
Favorite
(
P 179
)
IMMUNOSUPPRESSIVE MYELOID CELLS ARE INCREASED IN PATIENTS WITH SOFT TISSUE SARCOMA (STS) AND ARE NEGATIVELY ASSOCIATED WITH SURVIVAL
Sandro Pasquali
Favorite
(
P 188
)
PRELIMINARY ASSESSMENT OF CIRCULATING INFLAMMATORY CYTOKINES IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE) PATIENTS AND IN AN EHE PATIENT-DERIVED XENOGRAFT BEFORE AND AFTER DOXORUBICIN AND SIROLIMUS
Sandro Pasquali
Favorite
(
P 220
)
PROMOTING GLOBAL EDUCATION IN THE FIELD OF RETROPERITONEAL SARCOMA: THE FIRST OPEN-ACCESS EDUCATIONAL WEBINAR SERIES BY THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP
Sandro Pasquali
Favorite
Passarelli, Federico
Unit of Immunotherapy of Human Tumors, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori
(
P 179
)
IMMUNOSUPPRESSIVE MYELOID CELLS ARE INCREASED IN PATIENTS WITH SOFT TISSUE SARCOMA (STS) AND ARE NEGATIVELY ASSOCIATED WITH SURVIVAL
Federico Passarelli
Favorite
Patel, Jyoti D.
University of Chicago
(
P 107
)
LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT PATIENTS WITH TRK FUSION SARCOMAS
Jyoti D. Patel
Favorite
Patel, Shreyaskumar
The University of Texas MD Anderson Cancer Center
(
P 013
)
A PHASE 2 TRIAL OF CETUXIMAB FOR PATIENTS WITH LOCALLY ADVANCED/METASTATIC CHORDOMA
Shreyaskumar Patel
Favorite
Patel, Vivek
Cancer Institute (WIA)
(
P 093
)
TIME TO TREATMENT INITIATION IN PRIMARY EXTREMITY SARCOMA: AN ANALYSIS OF DATABASE FROM A REGIONAL CANCER CENTRE OF LOW/MIDDLE INCOME COUNTRY
Vivek Patel
Favorite
Patil, Priyanka
Tata Memorial Hospital Mumbai
(
P 09
)
OUTCOMES, PROGNOSTIC FACTORS AND TREATMENT COMPLIANCE IN OSTEOSARCOMA CASES TREATED WITH AN INDIGENOUS, LOW-COST PROTOCOL, OGS-12, IN A TERTIARY CARE CANCER CENTRE IN INDIA
Priyanka Patil
Favorite
Patil, Tejas
Department of Medicine, Division of Medical Oncology, University of Colorado
(
P 107
)
LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT PATIENTS WITH TRK FUSION SARCOMAS
Tejas Patil
Favorite
Patil, Vijay
Tata Memorial Centre
(
P 03
)
DEMOGRAPHICS, PRACTICE PATTERNS, CHALLENGES AND OUTCOMES OF SYNOVIAL SARCOMA PATIENTS FROM A TERTIARY CARE CENTRE FROM A LARGE LOW-MIDDLE INCOME COUNTRY
Vijay Patil
Favorite
(
P 09
)
OUTCOMES, PROGNOSTIC FACTORS AND TREATMENT COMPLIANCE IN OSTEOSARCOMA CASES TREATED WITH AN INDIGENOUS, LOW-COST PROTOCOL, OGS-12, IN A TERTIARY CARE CANCER CENTRE IN INDIA
Vijay Patil
Favorite
Patt, Joshua
Levine Cancer Institute
(
P 261
)
CLINICAL FEATURES AND TREATMENT OUTCOMES OF PATIENTS WITH DESMOID TUMORS: A LARGE SINGLE INSTITUTION RETROSPECTIVE SERIES
Joshua Patt
Favorite
Paulo, Joao
Harvard Medical School
(
P 099
)
CONCURRENT INHIBITION OF CDK2 ADDS TO THE ANTI-TUMOR ACTIVITY OF CDK4/6 INHIBITION IN GIST
Joao Paulo
Favorite
Paul, Ryan
Hackensack Meridian School of Medicine
(
P 095
)
A COLLABORATIVE MULTIDISCIPLINARY APPROACH MAY LEAD TO ENHANCED CLINICAL OUTCOMES AND QUALITY OF CARE FOR PATIENTS WITH DIFFUSE TGCT
Ryan Paul
Favorite
Paulussen, Michael
Vestische Children’s and Youth Hospital Datteln, Pediatric Hematology and Oncology, Datteln, Germany
(
P 040
)
TWO RARE SIDES OF ONE RARE DISEASE: EWING SARCOMA WITH AND AS SECONDARY MALIGNANCIES FROM THE EPIDEMIOLOGICAL AND CLINICAL ANALYSIS OF AN INTERNATIONAL TRIAL REGISTRY
Michael Paulussen
Favorite
pautier, patricia
CLCC gustave roussy
(
P 048
)
IMMUNE INFILTRATION AS PROGNOSTIC FACTORS IN METASTATIC LEIOMYOSARCOMA
patricia pautier
Favorite
(
P 060
)
TOWARD A NEW GENOMIC AND CLINICO-PATHOLOGIC CLASSIFICATION OF UTERINE ADENOSARCOMAS
patricia pautier
Favorite
Pauwels, Antoinette
The Life Raft Group
(
P 110
)
PHASE I RESULTS FROM A MULTI-PHASE COMPREHENSIVE GENOMIC SEQUENCING TUMOR STUDY IN GASTROINTESTINAL STROMAL TUMOR PATIENTS
Antoinette Pauwels
Favorite
Pavlick, Dean
Foundation Medicine
(
P 010
)
SPECTRUM OF EWING-LIKE FUSIONS AND SECONDARY GENOMIC ALTERATIONS FROM A LARGE NEXT GENERATION SEQUENCING (NGS) COMPREHENSIVE GENOMIC PROFILING (CGP) DATABASE
Dean Pavlick
Favorite
Pawel, Bruce
Children's Hospital Los Angeles
(
P 023
)
FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS TREATED WITH SURGERY ON AEWS1031: A REPORT FROM THE CHILDRENS ONCOLOGY GROUP
Bruce Pawel
Favorite
Payne, John
Pittsburgh Veterinary Specialty & Emergency Center
(
P 025
)
INCREASED ALDH1A1 AND ATOX1 GENE EXPRESSION AND COPPER LEVELS IN CANINE OSTEOSARCOMA PATIENTS
John Payne
Favorite
Pease, Patricia
St. Jude Children's Research Hospital
(
P 012
)
ACUTE CARDIAC CHANGES IN PEDIATRIC AND YOUNG ADULT SOLID TUMOR PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS
Patricia Pease
Favorite
Peirone, Serena
Department of Biosciences, University of Milan and Italian Institute for Genomic Medicine (Candiolo, Turin))
(
P 029
)
MOLECULAR CHARACTERIZATION OF OSTEOSARCOMA AND EWING SARCOMA IN PEDIATRIC PATIENTS REVEALS NOVEL RNA-BASED INTERVENTION POINTS.
Serena Peirone
Favorite
Pellegrini, Ilaria
University of Milan
(
P 145
)
A RETROSPECTIVE CASE SERIES ANALYSIS OF 22 RHABDOMYOSARCOMA PATIENTS WITH SPINDLE-CELL/SCLEROSING MORPHOLOGY
Ilaria Pellegrini
Favorite
PENEL, Nicolas
Centre Oscar Lambret
(
P 080
)
INTRACRANIAL SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA MANAGEMENT: A FRENCH MULTICENTRE RETROSPECTIVE STUDY
Nicolas PENEL
Favorite
Penninga, Luit
Department of Surgical Gastroenterology, Copenhagen University Hospital, Rigshospitalet
(
P 120
)
THE DIAGNOSTIC AND PROGNOSTIC VALUE OF PLASMA SMALL EXTRACELLULAR VESICLES PHENOTYPE IN PATIENTS WITH GASTROINTESTINAL STROMAL TUMOUR
Luit Penninga
Favorite
Percio, Stefano
Fondazione IRCCS Istituto Nazionale Tumori
(
P 170
)
ANTITUMOR ACTIVITY OF TAZEMETOSTAT AND DOXORUBICIN COMBINATION ON PATIENT-DERIVED PRECLINICAL MODELS OF EPITHELIOID SARCOMA
Stefano Percio
Favorite
Peretz Soroka, Hagit
Princess Margaret Cancer Centre
(
P 05
)
GENETIC ANALYSIS OF ADULT RMS: ARE THERE MOLECULAR ALTERATIONS THAT DRIVE INFERIOR OUTCOMES?
Hagit Peretz Soroka
Favorite
(
P 068
)
CLINICO-DEMOGRAPHIC CHARACTERISTICS AND OUTCOMES OF RADIATION-INDUCED SARCOMAS: A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) STUDY
Hagit Peretz Soroka
Favorite
(
P 165
)
REAL- WORLD EXPERIENCE OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH RECURRENT BONE TUMOURS (BT): A CANSARCC STUDY
Hagit Peretz Soroka
Favorite
(
P 290
)
OSTEOSARCOMA OF THE HEAD AND NECK (HN) IN ADULTS: A CANSARCC STUDY
Hagit Peretz Soroka
Favorite
Peretz, Idit
(
P 257
)
SELECTIVE INTRA-ARTERIAL DOXORUBICIN-ELUTING EMBOLIZATION FOR DESMOID FIBROMATOSIS: A COMBINED PROSPECTIVE AND RETROSPECTIVE STUDY
Idit Peretz
Favorite
Perez, Marco
Instituto de Biomedicina de Sevilla (IBiS)
(
P 161
)
PALBOSARC: A PHASE II TRIAL OF PALBOCICLIB IN ADVANCED SARCOMA OVEREXPRESSING CDK4 GENE EXCLUDING DEDIFFERENTIATED LIPOSARCOMA (DD LPS): A STUDY FROM THE SPANISH GROUP FOR RESEARCH ON SARCOMA (GEIS).
Marco Perez
Favorite
Pérez, Maria
Washington University in St. Louis
(
P 075
)
EXAMINING PATIENT PERSPECTIVES ON SARCOMA SURVEILLANCE: THE SARCOMA SURVEILLANCE SURVEY
Maria Pérez
Favorite
Perot, Gaelle
Toulouse Cancer Research Center
(
P 253
)
THE IMPACT OF CELL FUSION IN LEIOMYOSARCOMA ONCOGENESIS
Gaelle Perot
Favorite
Peterman, Mary
Regeneron Pharmaceuticals
(
P 131
)
MUCIN 16 (CANCER ANTIGEN 125) EXPRESSION IN EPITHELIOID SARCOMA LEADS TO SINGLE-PATIENT STUDY WITH BISPECIFIC T-CELL ENGAGER UBAMATAMAB (MUCIN16-CD3): A BENCH-TO-BEDSIDE EXPERIENCE
Mary Peterman
Favorite
Peters, Derek
Duke University School of Medicine
(
P 254
)
THE IMPACT OF MST (HIPPO KINASE) INHIBITION ON CHROMATIN ACCESSIBILITY AND ONCOGENIC PHENOTYPES IN FUSION-POSITIVE RHABDOMYOSARCOMA
Derek Peters
Favorite
Petersen, Ivy
Mayo Clinic
(
P 020
)
DEFINITIVE RADIATION THERAPY FOR EWING SARCOMA: TREATMENT AND TOXICITY OUTCOMES IN PATIENTS TREATED WITH DOSE ESCALATION APPROACHES
Ivy Petersen
Favorite
(
P 207
)
SPATIALLY FRACTIONATED RADIATION THERAPY IN SARCOMAS: THE MAYO CLINIC EXPERIENCE
Ivy Petersen
Favorite
Peterson, Nicholas
University of California, Los Angeles
(
P 286
)
INDICATIONS AND LONGEVITY OF ENDOPROSTHETIC RECONSTRUCTIONS FOR PATIENTS WITH METASTATIC BONE DISEASE
Nicholas Peterson
Favorite
Peyre, Matthieu
Paris-La-Pitié-salpêtrière
(
P 080
)
INTRACRANIAL SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA MANAGEMENT: A FRENCH MULTICENTRE RETROSPECTIVE STUDY
Matthieu Peyre
Favorite
Phillips, Marianne
Perth Children's Hospital
(
P 148
)
ANALYSIS OF REECUR TRIAL DATA TO EVALUATE POTENTIAL PROGNOSTIC FACTORS IN RECURRENT AND PRIMARY REFRACTORY EWING SARCOMA (RR-ES)
Marianne Phillips
Favorite
Piątkowski, Jakub
Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Warsaw, Poland
(
P 245
)
MUTATIONAL STATUS OF CHONDROSARCOMA BASED ON TARGETED NEXT-GENERATION SEQUENCING ANALYSIS
Jakub Piątkowski
Favorite
Piana, Raimondo
Orthopedic Oncologic Reconstructive Surgery, CTO Hospital, AOU Città della Salute e della Scienza di Torino
(
P 058
)
SARCOPENIA AS A NEGATIVE PROGNOSTIC FACTOR IN LOCALIZED EXTREMITIES/TRUNK WALL SOFT TISSUE SARCOMAS
Raimondo Piana
Favorite
Piccinelli, Paul
Lund University
(
P 242
)
LIPOSARCOMAS WITH 12Q AMPLIFICATION - CAN GENETIC CHANGES DISCLOSE THE DEVELOPMENT AND ORIGIN OF RING CHROMOSOMES?
Paul Piccinelli
Favorite
Pichler, Martin
Division of Clinical Oncology, Department of Internal Medicine, Medical University of Graz
(
P 141
)
TUMOUR-INFILTRATING IMMUNE CELLS IN SOFT TISSUE SARCOMA. IMPACT ON LOCAL RECURRENCE, DISTANT METASTASIS, AND OVERALL SURVIVAL.
Martin Pichler
Favorite
Piel, Jessica
Foghorn Therapeutics
(
P 187
)
PRECLINICAL VALIDATION OF TARGET ENGAGEMENT ASSAYS AND INVESTIGATION OF MECHANISTIC IMPACTS OF FHD-609, A CLINICAL-STAGE BRD9 DEGRADER BEING DEVELOPED FOR THE TREATMENT OF SYNOVIAL SARCOMA
Jessica Piel
Favorite
Pieri, Federica
Pathology Unit, Morgagni-Pierantoni Hospital, Forlì, Italy.
(
P 195
)
THE STRATEGIC ROLE OF 3D CULTURE SYSTEMS AND ZEBRAFISH NEAR-PATIENTS PRECLINICAL PLATFORMS AS PREDICTIVE TOOLS OF CHEMOTHERAPY RESPONSE FOR SARCOMA
Federica Pieri
Favorite
Pierini, Michela
Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies Unit IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
(
P 031
)
PAZOPANIB IN ADVANCED BONE SARCOMA: A RETROSPECTIVE ANALYSIS OF RIZZOLI ORTHOPEDIC INSTITUTE
Michela Pierini
Favorite
(
P 245
)
MUTATIONAL STATUS OF CHONDROSARCOMA BASED ON TARGETED NEXT-GENERATION SEQUENCING ANALYSIS
Michela Pierini
Favorite
Pietrok, Laura
University of Iowa Carver College of Medicine
(
P 159
)
NEOADJUVANT INTRATUMORAL HIGH DOSE TALIMOGENE LAHERPAREPVEC (TVEC) WITH CONCURRENT RADIATION IN HIGH-RISK EXTREMITY AND TRUNK SOFT-TISSUE SARCOMAS
Laura Pietrok
Favorite
(
P 160
)
NEOADJUVANT PHARMACOLOGICAL ASCORBATE WITH CONCURRENT RADIATION IN LOCALLY ADVANCED SOFT-TISSUE SARCOMA OF EXTREMITY/TRUNK AND RETROPERITONEUM
Laura Pietrok
Favorite
Pignoli, Emanuele
Department of Medical Physics, Fondazione IRCCS Istituto Nazionale Dei Tumori Milan (IT)
(
P 203
)
MULTIDISCIPLINARY APPROACH OF ADVANCED-STAGE ALVEOLAR RHABDOMYOSARCOMA OF THE MAXILLARY SINUS IN ADULTS: A CASE REPORT
Emanuele Pignoli
Favorite
Pillay, Nischalan
University College London and Royal National Orthopaedic Hospital
(
P 011
)
TACKLE A RARE SARCOMA THROUGH A COLLABORATIVE APPROACH
Nischalan Pillay
Favorite
(
P 252
)
THE GENOMIC LANDSCAPE OF CLEAR CELL SARCOMA RESEARCH INITIATIVE
Nischalan Pillay
Favorite
Pineño Flores, Cristina
Hospital universitario son espases
(
P 119
)
SURGICAL MANAGEMENT OF GASTROINTESTINAL STROMAL TUMOURS SARCOMATOSIS (GISTOSIS). A RETROSPECTIVE MULTI-INSTITUTIONAL STUDY
Cristina Pineño Flores
Favorite
Pinto, Navin
Seattle Children’s Hospital
(
P 239
)
FGFR IS A RELEVANT MOLECULAR TARGET IN PEDIATRIC AND AYA SARCOMAS
Navin Pinto
Favorite
Piorkowska, Karolina
Hospital for Sick Children
(
P 124
)
EFFECT OF MAGNETIC RESONANCE GUIDED HIGH INTENSITY FOCUSED ULTRASOUND AND CHEMOTHERAPY ON THE IMMUNE PROFILE OF A MURINE MODEL OF RHABDOMYOSARCOMA
Karolina Piorkowska
Favorite
Piórkowska, Paula
Faculty of Medicine, Medical University of Warsaw
(
P 166
)
SARCOMA BRAIN METASTASES: EXPERIENCE AT A SINGLE INSTITUTION
Paula Piórkowska
Favorite
Pissaloux, Daniel
CENTRE LEON BERARD
(
P 238
)
EXPANDING THE MOLECULAR SPECTRUM OF GIANT CELL TUMORS.
Daniel Pissaloux
Favorite
Plantaz, Dominique
CHU Grenoble
(
P 026
)
IS THERE STILL A PLACE FOR BONE MARROW SAMPLING IN VERY HIGH RISK EWING SARCOMA? ROLE OF FDG PET/CT IN THE INITIAL STAGING OF VERY HIGH RISK EWING SARCOMA IN A PROSPECTIVE PHASE II MULTICENTRIC STUDY.
Dominique Plantaz
Favorite
Plumlee, Sarah
Department of Orthopedic Surgery, Duke University
(
P 171
)
CANINE-DERIVED OSTEOSARCOMA ORGANOIDS MODEL TUMOR HETEROGENEITY AND CHEMOTHERAPY RESISTANCE
Sarah Plumlee
Favorite
Pockaj, Barbara
Mayo Clinic (Arizona)
(
P 289
)
MERKEL CELL CARCINOMA OF UNKNOWN PRIMARY: CLINICAL PRESENTATION AND OUTCOMES
Barbara Pockaj
Favorite
Poklepovic, Andrew
VCU Massey Cancer
(
P 144
)
A PHASE 1/2 DOSE ESCALATION/EXPANSION STUDY OF ZN-C3 PLUS GEMCITABINE IN RELAPSED/REFRACTORY OSTEOSARCOMA
Andrew Poklepovic
Favorite
Pokras, Shibani
RWE Lead, GSK
(
P 189
)
PROGNOSTIC IMPACT OF NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA-1 EXPRESSION AND HUMAN LEUKOCYTE ANTIGEN SUBTYPES IN METASTATIC SYNOVIAL SARCOMA
Shibani Pokras
Favorite
Pollok, Karen
Indiana University
(
P 192
)
TARGETING PI3K/MTOR MITIGATES RESISTANCE TO CDK4/6 INHIBITION IN RB-PROFICIENT PEDIATRIC AND AYA OSTEOSARCOMAS
Karen Pollok
Favorite
Posch, Florian
Division of Clinical Oncology, Department of Internal Medicine, Medical University of Graz
(
P 141
)
TUMOUR-INFILTRATING IMMUNE CELLS IN SOFT TISSUE SARCOMA. IMPACT ON LOCAL RECURRENCE, DISTANT METASTASIS, AND OVERALL SURVIVAL.
Florian Posch
Favorite
Powers, Benjamin
The University of Kansas Health System
(
P 028
)
LONG TERM SURVIVAL OF AN ANTERIOR SKULL BASE OSTEOSARCOMA ARISING FROM FIBROUS DYSPLASIA TREATED WITH TRIMODALITY THERAPY
Benjamin Powers
Favorite
Pozas, Javier
Department of Medical Oncology, Ramón y Cajal University Hospital
(
P 157
)
MOLECULAR SCREENING OF ADVANCED SARCOMAS THROUGH NEXT-GENERATION SEQUENCING IN A TERTIARY UNIVERSITY HOSPITAL
Javier Pozas
Favorite
Prabhash, Kumar
Tata Memorial Centre
(
P 03
)
DEMOGRAPHICS, PRACTICE PATTERNS, CHALLENGES AND OUTCOMES OF SYNOVIAL SARCOMA PATIENTS FROM A TERTIARY CARE CENTRE FROM A LARGE LOW-MIDDLE INCOME COUNTRY
Kumar Prabhash
Favorite
(
P 09
)
OUTCOMES, PROGNOSTIC FACTORS AND TREATMENT COMPLIANCE IN OSTEOSARCOMA CASES TREATED WITH AN INDIGENOUS, LOW-COST PROTOCOL, OGS-12, IN A TERTIARY CARE CANCER CENTRE IN INDIA
Kumar Prabhash
Favorite
Pressey, Joseph G.
Cancer and Blood Diseases Institute, Cincinnati Children's Hospital
(
P 118
)
SOMATOSTATIN RECEPTOR TYPE 2 EXPRESSION IN SARCOMA
Joseph G. Pressey
Favorite
(
P 144
)
A PHASE 1/2 DOSE ESCALATION/EXPANSION STUDY OF ZN-C3 PLUS GEMCITABINE IN RELAPSED/REFRACTORY OSTEOSARCOMA
Joseph G. Pressey
Favorite
Preziuso, Marzia
Humanitas Clinical and Research Center, IRCCS, Rozzano, 20089, Italy.
(
P 08
)
HOW TO DEVELOP AN ADOLESCENT AND YOUNG PROGRAM IN AN ADULT CANCER CENTER: THE HUMANITAS RESEARCH HOSPITAL EXPERIENCE
Marzia Preziuso
Favorite
Priante, Francesca
Italian Institute for Genomic Medicine and Department of Physics, University of Turin
(
P 029
)
MOLECULAR CHARACTERIZATION OF OSTEOSARCOMA AND EWING SARCOMA IN PEDIATRIC PATIENTS REVEALS NOVEL RNA-BASED INTERVENTION POINTS.
Francesca Priante
Favorite
Prietl, Barbara
Center for Biomarker Research in Medicine (CBmed)
(
P 141
)
TUMOUR-INFILTRATING IMMUNE CELLS IN SOFT TISSUE SARCOMA. IMPACT ON LOCAL RECURRENCE, DISTANT METASTASIS, AND OVERALL SURVIVAL.
Barbara Prietl
Favorite
Pringle, Toni
School of Natural and Environmental Sciences, Newcastle University, UK
(
P 172
)
DEVELOPMENT OF A TARGETED DUAL-MODALITY RADIOIMMUNOCONJUGATE FOR IMAGE GUIDED SARCOMA SURGERY
Toni Pringle
Favorite
Provenzano, Salvatore
Fondazione IRCCS Istituto Nazionale dei Tumori
(
P 145
)
A RETROSPECTIVE CASE SERIES ANALYSIS OF 22 RHABDOMYOSARCOMA PATIENTS WITH SPINDLE-CELL/SCLEROSING MORPHOLOGY
Salvatore Provenzano
Favorite
(
P 203
)
MULTIDISCIPLINARY APPROACH OF ADVANCED-STAGE ALVEOLAR RHABDOMYOSARCOMA OF THE MAXILLARY SINUS IN ADULTS: A CASE REPORT
Salvatore Provenzano
Favorite
Provenzano, Sylvio
Gold Coast University Hospital
(
P 299
)
PULMONARY METASTASECTOMY OF OSTEOSARCOMA VIA PNEUMONECTOMY AND MEDIAN STERNOTOMY WITH COMPLETE INTRATHORACIC LIVER MIGRATION: A CASE REPORT
Sylvio Provenzano
Favorite
Przybyl, Joanna
McGill University
(
P 240
)
GLYCOSYLATION SITES IN MOLECULAR DRIVERS OF SARCOMA
Joanna Przybyl
Favorite
Puduvalli, Vinay
MD Anderson Cancer Center
(
P 013
)
A PHASE 2 TRIAL OF CETUXIMAB FOR PATIENTS WITH LOCALLY ADVANCED/METASTATIC CHORDOMA
Vinay Puduvalli
Favorite
Puertas, Pablo
“La Arrixaca” Clinical University Hospital
(
P 055
)
PROGNOSTIC VALUE AND USEFULNESS OF HAEMATOLOGICAL BIOMARKERS IN LIPOSARCOMAS.
Pablo Puertas
Favorite
Puertas, Pablo
HCU VIRGEN ARRIXACA
(
P 318
)
NEOADJUVANT CHEMORADIOTHERAPY IN ADVANCED SOFT TISSUE SARCOMA. UPDATED NASAR STUDY
Pablo Puertas
Favorite
Puertes, Ana
HCU VIRGEN ARRIXACA
(
P 318
)
NEOADJUVANT CHEMORADIOTHERAPY IN ADVANCED SOFT TISSUE SARCOMA. UPDATED NASAR STUDY
Ana Puertes
Favorite
Puloski, Shannon
University of Calgary
(
P 205
)
PREOPERATIVE CHEMORADIATION (MODIFIED EILBER PROTOCOL) VERSUS NEOADJUVANT/ ADJUVANT RADIOTHERAPY FOR SOFT TISSUE EXTREMITY SARCOMAS: A POPULATION BASED ANALYSIS IN ALBERTA
Shannon Puloski
Favorite
(
P 286
)
INDICATIONS AND LONGEVITY OF ENDOPROSTHETIC RECONSTRUCTIONS FOR PATIENTS WITH METASTATIC BONE DISEASE
Shannon Puloski
Favorite
Pultar, Philippe
Zentalis Pharmaceuticals
(
P 144
)
A PHASE 1/2 DOSE ESCALATION/EXPANSION STUDY OF ZN-C3 PLUS GEMCITABINE IN RELAPSED/REFRACTORY OSTEOSARCOMA
Philippe Pultar
Favorite
Puma, Nadia
Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
(
P 016
)
ACTIVITY OF CHEMOTHERAPY IN MESENCHYMAL CHONDROSARCOMA: A MULTICENTRE RETROSPECTIVE ANALYSIS WITHIN THE ITALIAN SARCOMA GROUP
Nadia Puma
Favorite
Purgina, Bibianna
The University of Ottawa
(
P 112
)
PREVALENCE AND PROGNOSTIC VALUE OF TARGETABLE RECEPTORS IN EXTRA-UTERINE LEIOMYOSARCOMA
Bibianna Purgina
Favorite
(
P 197
)
TUMOR IMMNUNE PROFILING AND IDENTIFICATION OF IMMUNOTHERAPEUTIC TARGETS IN DEDIFFERENTIATED LIPOSARCOMA
Bibianna Purgina
Favorite
Back to Top
